Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Current Leases (2019 - 2025)

IDEAYA Biosciences' Current Leases history spans 7 years, with the latest figure at $339000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 13.76% year-over-year to $339000.0; the TTM value through Dec 2025 reached $339000.0, up 13.76%, while the annual FY2025 figure was $339000.0, 13.76% up from the prior year.
  • Current Leases for Q4 2025 was $339000.0 at IDEAYA Biosciences, up from $328000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $2.1 million in Q3 2023 and bottomed at $298000.0 in Q4 2024.
  • The 5-year median for Current Leases is $1.7 million (2021), against an average of $1.3 million.
  • The largest annual shift saw Current Leases skyrocketed 34.18% in 2021 before it crashed 82.94% in 2024.
  • A 5-year view of Current Leases shows it stood at $1.7 million in 2021, then grew by 10.12% to $1.9 million in 2022, then fell by 6.63% to $1.7 million in 2023, then plummeted by 82.94% to $298000.0 in 2024, then increased by 13.76% to $339000.0 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Current Leases are $339000.0 (Q4 2025), $328000.0 (Q3 2025), and $318000.0 (Q2 2025).